Welcome to our dedicated page for CROWN RESV ACQUISITION I news (Ticker: CRACU), a resource for investors and traders seeking the latest updates and insights on CROWN RESV ACQUISITION I stock.
Crown Reserve Acquisition Corp. I is a blank-check company whose news centers on SPAC financing, security structure, and governance developments. Updates include the completed initial public offering of CRACU units, the composition of each unit as a Class A ordinary share, one-half redeemable warrant, and one right, and the placement of IPO proceeds into a trust account. Company announcements also address separate trading mechanics for Class A shares, warrants, and rights, along with material agreements, shareholder voting matters, capital-structure disclosures, operating results, and governance items tied to its pursuit of an initial business combination.
Crown Reserve Acquisition Corp. I (Nasdaq: CRACR) and Carvix agreed to a definitive business combination that values Carvix at an implied enterprise value of $1.0 billion including earnouts.
The deal contemplates an all-stock merger, a targeted $80.0 million PIPE, a committed $20.0 million equity line, a minimum post-redemption cash requirement of $10.0 million, and up to 50,000,100 earnout shares over four years. The combined company expects to list on Nasdaq; closing is subject to customary approvals and a Sept 30, 2026 outside date.
Crown Reserve Acquisition Corp. I (NASDAQ: CRACU) announced that, commencing on or about December 9, 2025, holders of units sold in its IPO may elect to separately trade the Class A ordinary shares, warrants, and rights included in the units.
The separated securities are expected to trade on Nasdaq under the symbols CRAC (Class A ordinary shares), CRACW (warrants), and CRACR (rights); units that remain intact will continue trading as CRACU. No fractional warrants will be issued; only whole warrants will trade. Unit holders must have their broker contact VStock Transfer, LLC to effect separation. The company filed a registration statement that became effective on September 26, 2025.
Crown Reserve Acquisition Corp. I (Nasdaq: CRACU) closed its initial public offering on Nov 10, 2025, issuing 17,250,000 units at $10.00 per unit (including a full 2,250,000-unit over-allotment) for gross proceeds of $172,500,000. Each unit comprises one Class A ordinary share, one-half warrant, and one Share Right to receive one-fifth of a share upon a business combination.
An amount equal to $10.00 per unit was deposited into a trust account. Units began trading on Nasdaq on Nov 7, 2025 under CRACU; separate trading of components is expected under CRAC / CRACW / CRACR. The company is a blank check vehicle targeting acquisitions in pharma, medical technology, medical equipment, and healthcare IT. Management includes Prashant Patel (CEO) and Eric Sherb (CFO).
Crown Reserve Acquisition Corp. I (Nasdaq: CRACU) priced a $150,000,000 initial public offering of 15,000,000 units at $10.00 per unit. Units begin trading on Nov 7, 2025 and the offering is expected to close on Nov 10, 2025, subject to customary conditions. Each unit contains one Class A share, one-half of a redeemable warrant and one Share Right convertible into one-fifth of a Class A share; whole warrants exercise at $11.50. An amount equal to $10.00 per unit will be deposited into a trust account. The company granted underwriters a 45-day option to purchase up to 2,250,000 additional units (15%). Management includes CEO/Chair Prashant Patel and CFO/director Eric Sherb.